Quest Diagnostics Incorporated (LON:0KSX)
London · Delayed Price · Currency is GBP · Price in USD 210.18
+2.18 (1.05%)
Feb 12, 2026, 5:06 PM GMT
Quest Diagnostics Market Cap
Quest Diagnostics has a market cap or net worth of 16.88 billion as of February 12, 2026. Its market cap has increased by 19.66% in one year.
Market Cap
16.88B
Enterprise Value
21.33B
Revenue
8.20B
Ranking
n/a
PE Ratio
22.99
Stock Price
210.18
Market Cap Chart
Since December 17, 1996, Quest Diagnostics's market cap has increased from 240.44M to 16.88B, an increase of 6,918.74%. That is a compound annual growth rate of 15.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 16.88B | 17.66% |
| Dec 31, 2025 | 14.34B | 6.64% |
| Dec 31, 2024 | 13.45B | 10.51% |
| Dec 29, 2023 | 12.17B | -17.69% |
| Dec 30, 2022 | 14.79B | -5.66% |
| Dec 31, 2021 | 15.67B | 33.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Convatec Group | 4.37B |
| Hikma Pharmaceuticals | 3.43B |
| Genus | 2.09B |
| HUTCHMED (China) | 1.88B |